Omada Health加入礼来雇主连接计划，扩大GLP-1疗法通路以满足患者生活方式支持需求

美股速递

May 08

数字健康企业Omada Health正式加入礼来制药的雇主连接平台，此举显著拓宽了其GLP-1代谢类药物的服务覆盖网络。随着越来越多患者寻求全面的生活方式管理支持，该合作将通过整合临床干预与行为科学，为慢性病患者提供个性化治疗方案。

通过接入礼来的雇主级医疗生态系统，Omada Health将能直接为企业员工提供包含GLP-1药物在内的综合代谢疾病管理服务。这种创新模式突破了传统医疗服务的碎片化壁垒，将药物治疗与数字化健康指导深度融合。研究表明，结合持续生活方式干预的GLP-1疗法可使患者减重效果提升三成以上。

当前医疗市场正经历结构性变革。患者不再满足于单一药物治疗，转而追求涵盖营养指导、运动规划、心理支持的全周期健康管理。Omada Health的加入恰逢其时，其特有的数据驱动平台能实时追踪患者生理指标，动态调整干预策略。这种精准化服务模式正逐渐成为行业新标准。

此次合作也反映了制药企业与数字健康平台融合的加速趋势。礼来通过开放其雇主网络，赋能数字化医疗服务商触达更广泛人群，而Omada Health则凭借其行为改变技术优势，助力提升药物疗法的长期依从性。这种跨界协同有望重塑慢性病管理的价值链。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1138971090"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1138971090\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1138971090?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-05-08 04:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1138971090","market":"us","top_or_hot":-1,"title":"Omada Health加入礼来雇主连接计划，扩大GLP-1疗法通路以满足患者生活方式支持需求","media":"美股速递","content":"<p>数字健康企业Omada Health正式加入礼来制药的雇主连接平台，此举显著拓宽了其GLP-1代谢类药物的服务覆盖网络。随着越来越多患者寻求全面的生活方式管理支持，该合作将通过整合临床干预与行为科学，为慢性病患者提供个性化治疗方案。</p>\n<p>通过接入礼来的雇主级医疗生态系统，Omada Health将能直接为企业员工提供包含GLP-1药物在内的综合代谢疾病管理服务。这种创新模式突破了传统医疗服务的碎片化壁垒，将药物治疗与数字化健康指导深度融合。研究表明，结合持续生活方式干预的GLP-1疗法可使患者减重效果提升三成以上。</p>\n<p>当前医疗市场正经历结构性变革。患者不再满足于单一药物治疗，转而追求涵盖营养指导、运动规划、心理支持的全周期健康管理。Omada Health的加入恰逢其时，其特有的数据驱动平台能实时追踪患者生理指标，动态调整干预策略。这种精准化服务模式正逐渐成为行业新标准。</p>\n<p>此次合作也反映了制药企业与数字健康平台融合的加速趋势。礼来通过开放其雇主网络，赋能数字化医疗服务商触达更广泛人群，而Omada Health则凭借其行为改变技术优势，助力提升药物疗法的长期依从性。这种跨界协同有望重塑慢性病管理的价值链。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Omada Health加入礼来雇主连接计划，扩大GLP-1疗法通路以满足患者生活方式支持需求</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOmada Health加入礼来雇主连接计划，扩大GLP-1疗法通路以满足患者生活方式支持需求\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1004306016\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">美股速递 </p>\n<p class=\"h-time\">2026-05-08 04:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>数字健康企业Omada Health正式加入礼来制药的雇主连接平台，此举显著拓宽了其GLP-1代谢类药物的服务覆盖网络。随着越来越多患者寻求全面的生活方式管理支持，该合作将通过整合临床干预与行为科学，为慢性病患者提供个性化治疗方案。</p>\n<p>通过接入礼来的雇主级医疗生态系统，Omada Health将能直接为企业员工提供包含GLP-1药物在内的综合代谢疾病管理服务。这种创新模式突破了传统医疗服务的碎片化壁垒，将药物治疗与数字化健康指导深度融合。研究表明，结合持续生活方式干预的GLP-1疗法可使患者减重效果提升三成以上。</p>\n<p>当前医疗市场正经历结构性变革。患者不再满足于单一药物治疗，转而追求涵盖营养指导、运动规划、心理支持的全周期健康管理。Omada Health的加入恰逢其时，其特有的数据驱动平台能实时追踪患者生理指标，动态调整干预策略。这种精准化服务模式正逐渐成为行业新标准。</p>\n<p>此次合作也反映了制药企业与数字健康平台融合的加速趋势。礼来通过开放其雇主网络，赋能数字化医疗服务商触达更广泛人群，而Omada Health则凭借其行为改变技术优势，助力提升药物疗法的长期依从性。这种跨界协同有望重塑慢性病管理的价值链。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"","article_id":"1138971090","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1138971090","pubTimestamp":1778184745,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"数字健康企业Omada Health正式加入礼来制药的雇主连接平台，此举显著拓宽了其GLP-1代谢类药物的服务覆盖网络。通过接入礼来的雇主级医疗生态系统，Omada Health将能直接为企业员工提供包含GLP-1药物在内的综合代谢疾病管理服务。研究表明，结合持续生活方式干预的GLP-1疗法可使患者减重效果提升三成以上。礼来通过开放其雇主网络，赋能数字化医疗服务商触达更广泛人群，而Omada Health则凭借其行为改变技术优势，助力提升药物疗法的长期依从性。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4196":"保健护理服务","OMDA":"Omada Health"},"translate_title":"Omada Health Joins Eli Lilly's Employer Connect Program to Expand GLP-1 Therapy Pathways to Meet Patient Lifestyle Support Needs","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMDA":1},"content_text":"数字健康企业Omada Health正式加入礼来制药的雇主连接平台，此举显著拓宽了其GLP-1代谢类药物的服务覆盖网络。随着越来越多患者寻求全面的生活方式管理支持，该合作将通过整合临床干预与行为科学，为慢性病患者提供个性化治疗方案。\n通过接入礼来的雇主级医疗生态系统，Omada Health将能直接为企业员工提供包含GLP-1药物在内的综合代谢疾病管理服务。这种创新模式突破了传统医疗服务的碎片化壁垒，将药物治疗与数字化健康指导深度融合。研究表明，结合持续生活方式干预的GLP-1疗法可使患者减重效果提升三成以上。\n当前医疗市场正经历结构性变革。患者不再满足于单一药物治疗，转而追求涵盖营养指导、运动规划、心理支持的全周期健康管理。Omada Health的加入恰逢其时，其特有的数据驱动平台能实时追踪患者生理指标，动态调整干预策略。这种精准化服务模式正逐渐成为行业新标准。\n此次合作也反映了制药企业与数字健康平台融合的加速趋势。礼来通过开放其雇主网络，赋能数字化医疗服务商触达更广泛人群，而Omada Health则凭借其行为改变技术优势，助力提升药物疗法的长期依从性。这种跨界协同有望重塑慢性病管理的价值链。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}